Novo Nordisk invests $2.3 billion in France to boost obesity drug production
Novo Nordisk (NOVOb.CO) on Thursday announced a $2.3 billion investment to boost production of its wildly popular weight-loss and diabetes drugs at a site in Chartres, France as it races ...